FDA strengthens labelling for cardiovascular risks of glitazones News item 30 January 2013 Pages: 2 - 2
Oxford GlycoSciences has temporarily halted miglustat [OGT 918, `Vevesca'] treatment in Israel Media release 30 January 2013 Pages: 2 - 2
Sirolimus not recommended for use following liver transplant Correspondence 30 January 2013 Pages: 2 - 2
Emergency safety information issued for olanzapine in Japan Media release 30 January 2013 Pages: 3 - 3
Levobupivacaine: reduced cardiac and CNS toxicity vs bupivacaine? Review 30 January 2013 Pages: 3 - 3
NAT2 polymorphisms increase the risk of isoniazid-induced hepatitis Clinical study 30 January 2013 Pages: 4 - 4
Atyptical antipsychotics associated with diabetes mellitus Incidence study 30 January 2013 Pages: 4 - 4
Peripheral nerve hyperexcitability causes oxaliplatin neurotoxicity Clinical study 30 January 2013 Pages: 5 - 5
Risk estimates of antihistamine-induced cardiac arrhythmias biased? Incidence study 30 January 2013 Pages: 5 - 5